TABLE 1.
Assay | Substrate and measurement | Application |
---|---|---|
OGT activity | UDP-[3H]GlcNAc; CKII aa340-352; measure µCi GlcNAc incorporated (Zachara et al., 2011) | Can be performed with crude preparations (∼20–50 μg protein) or purified OGT enzyme (∼0.2–1.0 μg protein), sensitive to salt inhibition (Zachara et al., 2011; Groves et al., 2017) |
OGT activity | Measure chemosensor binding, since it binds stronger with UDP than UDP-sugar (Kim, 2011) | The chemosensor binds more strongly to UDP than to the UDP-GlcNAc nucleotide-sugar donor and may be used to detect changes in O-GlcNAc incorporation. The chemosensor used may have nonspecific interactions with other cellular components |
OGT activity | Measure ligand displacement using fluorescent UDP-GlcNAc analogs and an active sOGT enzyme (Kim, 2011) | Purified enzyme is needed. This method can be used for the screening of OGT inhibitors |
OGA activity | Measure absorbance or fluorescence changes for synthetic substrates pNP-β-GlcNAc (400 nm) (Zachara et al., 2011) or 4MU-β-GlcNAc (excitation 360 nm, emission 450 nm) (Groves et al., 2017) | Can be performed with cell extracts (20–50 μg protein); GalNAc can be included in the reaction to inhibit lysosomal hexosaminidases A and B at a concentration that does not inhibit OGA, or the activities on GalNAc substrates can be subtracted from those on GlcNAc substrates (Zachara et al., 2011; Groves et al., 2017) |